82
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Association of Serum Renalase Levels and Renalase rs10887800 Polymorphism with Unstable Angina Pectoris Patients Having Metabolic Syndrome

, & ORCID Icon
Pages 3249-3259 | Published online: 15 Sep 2020

References

  • Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71(4):699–708. doi:10.1161/01.CIR.71.4.699
  • Mauro F, Tiziana S, Di Cristo F, et al. Metabolic syndrome, mediterranean diet, and polyphenols: evidence and perspectives. 2019
  • Shahbazian H, Latifi SM, Jalali MT, et al. Metabolic syndrome and its correlated factors in an urban population in South West of Iran. J Diabetes Metab Disord. 2013;12(1):11. doi:10.1186/2251-6581-12-11
  • Kaykhaei MA, Hashemi M, Narouie B, et al. Prevalence of metabolic syndrome in adult population from Zahedan, southeast Iran. Iran J Public Health. 2012;41(2):70.
  • Azizi F, Madjid M, Rahmani M, Emami H, Mirmiran P, Hadjipour R. Tehran lipid and glucose study (TLGS): rationale and design. Iran J Endocrinol Metab. 2000;2:77–86.
  • Shayestefar M, Haghighi KS, Jahanfar S, Delvarianzadeh M, Nematzadeh F, Ebrahimi MH. Assessment of the relationship between metabolic syndrome and obstructive sleep apnea in male drivers of Shahroud city in 2018: a cross sectional study. BMC Public Health. 2019;19(1):1058. doi:10.1186/s12889-019-7361-5
  • Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769–1778. doi:10.2337/diacare.28.7.1769
  • Braunwald E, Jones RH, Mark DB, et al. Diagnosing and managing unstable angina. Agency for health care policy and research. Circulation. 1994;90(1):613–622. doi:10.1161/01.CIR.90.1.613
  • Hamm CW, Bleifeld W. Unstable angina: current concepts of medical management. Cardiovasc Drugs Ther. 1988;2(3):333–339. doi:10.1007/BF00054640
  • Pokras R Detailed diagnoses and procedures for patients discharged from short-stay hospitals, United States; 1985. 1987
  • Makki N, Brennan TM, Girotra S. Acute coronary syndrome. J Intensive Care Med. 2015;30(4):186–200. doi:10.1177/0885066613503294
  • Hoseini Z, Azimi‐Nezhad M, Ghayour‐Mobarhan M, et al. VEGF gene polymorphism interactions with dietary trace elements intake in determining the risk of metabolic syndrome. J Cell Biochem. 2019;120(2):1398–1406. doi:10.1002/jcb.27171
  • Xu J, Li G, Wang P, et al. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J CLIN INVEST. 2005;115(5):1275–1280.
  • Desir GV. Regulation of blood pressure and cardiovascular function by renalase. Kidney Int. 2009;76(4):366–370. doi:10.1038/ki.2009.169
  • Bellia A, Giardina E, Lauro D, et al. “The linosa study”: epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. Nutr Metab Cardiovasc Dis. 2009;19(7):455–461. doi:10.1016/j.numecd.2008.11.002
  • Bosy-Westphal A, Onur S, Geisler C, et al. Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study. Int J Obes. 2007;31(5):784. doi:10.1038/sj.ijo.0803481
  • Elder SJ, Lichtenstein AH, Pittas AG, et al. Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome. J Lipid Res. 2009;50(9):1917–1926. doi:10.1194/jlr.P900033-JLR200
  • Shah SH, Hauser ER, Bain JR, et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol. 2009;5(1):258. doi:10.1038/msb.2009.11
  • Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; international. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
  • Bagci B, Karakus S, Bagci G, Sancakdar E. Renalase gene polymorphism is associated with increased blood pressure in preeclampsia. Pregnancy Hypertens an Int J Women’s Cardiovasc Heal. 2016;6(2):115–120.
  • Isomaa BO, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–689. doi:10.2337/diacare.24.4.683
  • National Cholesterol Education Program. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). circulation. 2002;106:3143–3421. doi:10.1161/circ.106.25.3143
  • Feinberg MS, Schwartz R, Tanne D, et al. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol. 2007;99(5):667–672. doi:10.1016/j.amjcard.2006.10.023
  • Teimoori B, Moradi-Shahrebabak M, Rezaei M, Mohammadpour-Gharehbagh A, Salimi S. Renalase rs10887800 polymorphism is associated with severe pre-eclampsia in southeast Iranian women. J Cell Biochem. 2019;120(3):3277–3285. doi:10.1002/jcb.27595
  • Desir GV, Peixoto AJ. Renalase in hypertension and kidney disease. Nephrol Dial Transplant. 2013;29(1):22–28. doi:10.1093/ndt/gft083
  • Desir GV, Tang L, Wang P, et al. Renalase lowers ambulatory blood pressure by metabolizing circulating adrenaline. J Am Heart Assoc. 2012;1(4):e002634. doi:10.1161/JAHA.112.002634
  • Boomsma F, Tipton KF. Renalase, a catecholamine-metabolising enzyme? J Neural Transm. 2007;114(6):775. doi:10.1007/s00702-007-0672-1
  • Ficek J, Małyszko J, Chudek J. Renalase and its role in the development of hypertension in patients with chronic renal failure. Przegl Lek. 2015;72(6):306–308.
  • Wybraniec MT, Mizia-Stec K, Trojnarska O, et al. Low plasma renalase concentration in hypertensive patients after surgical repair of coarctation of aorta. J AM SOC HYPERTENS. 2014;8(7):464–474.
  • Buraczynska M, Zukowski P, Buraczynska K, Mozul S, Ksiazek A. Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med. 2011;13(4):321–327. doi:10.1007/s12017-011-8158-6
  • Stec A. Rs10887800 renalase gene polymorphism influences the level of circulating renalase in patients undergoing hemodialysis but not in healthy controls. BMC Nephrol. 2017;18(1):118. doi:10.1186/s12882-017-0543-4
  • Steć A. Effect of renalase (RNLS) gene polymorphisms (rs1088700 and rs2576178) on plasma RNLS level in hemodialyzed patients affected by arterial hypertension and coronary artery disease. Polish J Public Heal. 2017;127(4):147–150. doi:10.1515/pjph-2017-0031
  • Wang F, Huang B, Li J, Liu L, Wang N. Renalase might be associated with hypertension and insulin resistance in Type 2 diabetes. Ren Fail. 2014;36(4):552–556. doi:10.3109/0886022X.2013.876352
  • Li X, Jiang W, Li L, et al. Renalase gene polymorphism in patients with hypertension and concomitant coronary heart disease. Kidney Blood Press Res. 2014;39(1):9–16. doi:10.1159/000355771